Stone Removal Helps Half of Patients With Recurrent UTI

This article originally appeared here.
Share this content:
Stone Removal Helps Half of Patients With Recurrent UTI
Stone Removal Helps Half of Patients With Recurrent UTI

FRIDAY, Sept. 25, 2015 (HealthDay News) -- Half of patients with recurrent urinary tract infections and asymptomatic renal calculi can be rendered infection-free with stone extraction, according to a study published in the October issue of The Journal of Urology.

Mohamed Omar, M.D., from the Cleveland Clinic, and colleagues retrospectively reviewed charts to identify 120 patients with recurrent urinary tract infections and nonobstructive renal stones who underwent surgical stone extraction and were declared stone-free. Demographic characteristics, as well as procedure, infectious etiology, stone composition, and the systemic inflammatory response syndrome rate, were assessed. Patients were classified based on recurrent infection after surgery: Group 1 (58 patients) had no evidence of recurrent infection, and group 2 (62 patients) had infections develop.

The researchers found that factors associated with a higher risk of recurrent infections included type 2 diabetes mellitus (odds ratio [OR], 1.73), hypertension (OR, 2.8), and black ethnicity (OR, 13.7). Infections with Escherichia coli were more likely to resolve (OR, 0.34), whereas Enterococcus infections were more likely to persist (OR, 2.5). Only race, hypertension, and E. coli infections were significant predictors of infection clearance on multiple logistic regression analysis.

"Patients with risk factors for recurrent infections after surgery should be counseled that stone extraction might not eradicate the infection," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »